Biologicals

Typhoid fever

Typhoid polysaccharide vaccine

Title: Requirements for Vi Polysaccharide Typhoid Vaccine; Adopted 1992, TRS No 840, Annex 1

Typhoid vaccine, live attenuated

Title: Requirements for Typhoid Vaccine (Live, attenuated, Ty 21a, Oral); Adopted at ECBS 1983 Reference:TRS No 700, Annex 3

Typhoid vaccine

Title: Requirements for Typhoid Vaccine; Adopted 1966, TRS No 361, Annex 4

UPCOMING EVENTS


  • WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015
  • WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015
  • WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WCC, Geneva, Switzerland, 27–28 April 2015
  • WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WCC, Geneva, Switzerland, 29–30 April 2015

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971